Neuro-QoL measures were developed through a collaborative, multisite NINDS-sponsored research initiative to construct a psychometrically-sound, and clinically-relevant, health-related quality of life
F-Values and p-values are indicated for a 2-way ANOVA (factor “group”: HS, DBN; factor “condition”: walking with slow, preferred and maximal speed, walking with eyes closed).Abbreviations: HS - health
Several neurological disorders may be amenable to treatment with gene-targeting therapies such as antisense oligonucleotides (ASOs) or viral vector-based gene therapy. The US FDA has approved several
